Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Gains from Investment Securities: 2012-2024

Historic Gains from Investment Securities for Fortress Biotech (FBIO) over the last 12 years, with Dec 2024 value amounting to $9.0 million.

  • Fortress Biotech's Gains from Investment Securities rose 369.57% to $540,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $540,000, marking a year-over-year decrease of 67.95%. This contributed to the annual value of $9.0 million for FY2024, which is 6641.42% up from last year.
  • Latest data reveals that Fortress Biotech reported Gains from Investment Securities of $9.0 million as of FY2024, which was up 6,641.42% from $133,503 recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Gains from Investment Securities ranged from a high of $9.0 million in FY2024 and a low of $35,000 during FY2021.
  • For the 3-year period, Fortress Biotech's Gains from Investment Securities averaged around $3.7 million, with its median value being $2.0 million (2022).
  • In the last 5 years, Fortress Biotech's Gains from Investment Securities slumped by 93.33% in 2023 and then surged by 6,641.42% in 2024.
  • Fortress Biotech's Gains from Investment Securities (Yearly) stood at $257,011 in 2020, then crashed by 86.38% to $35,000 in 2021, then skyrocketed by 5,621.43% to $2.0 million in 2022, then plummeted by 93.33% to $133,503 in 2023, then soared by 6,641.42% to $9.0 million in 2024.